Viewing Study NCT05816694


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-01-25 @ 9:16 AM
Study NCT ID: NCT05816694
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-04-18
First Post: 2023-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train.
Sponsor:
Organization: